Olga Meystelman

Olga Meystelman has extensive work experience in the healthcare industry. Olga is currently working as an Associate Director at CTMC, a joint venture between Resilience and MD Anderson Cancer Center. Prior to this, they held the position of Associate Director at Merck since 2020. Meystelman also worked at Celgene, where they served as a Manager from 2018 to 2020, and as a Specialist and Supervisor from 2010 to 2020.

Olga Meystelman completed their Bachelor's degree in Biology, General at Temple University in 2004. Olga later pursued a Master of Science (M.S.) degree in Quality Assurance/Regulatory Affairs from the same university, graduating in 2017.